-
Trial Show Ofev Benefits IPF Patients Irrespective of Initial Prognosis
Our latest flash briefing discusses a trials’ data that shows how Ofev benefits IPF patients irrespective of initial prognosis.
What are your thoughts about this trial and its findings?
Sorry, there were no replies found.
Log in to reply.